Use of selective-serotonin reuptake inhibitors and platelet aggregation inhibitors among individuals with co-occurring atherosclerotic cardiovascular disease and depression or anxiety. [electronic resource]
- SAGE open medicine 2016
- 2050312116682255 p. digital